Amferia develops innovative medical devices to provide solutions to the global antibiotic resistance crisis. Amferia’s goal is to provide highly efficient anti-infective medical devices that can prevent infections.
Location: United States, New York, Sweden
Employees: 11-50
Total raised: $1.33M
Founded date: 2018
Investors 3
Date | Name | Website |
- | BioVenture... | azbioventu... |
- | Almi Inves... | almi.se |
- | Chalmers V... | chalmersve... |
Funding Rounds 1
Date | Series | Amount | Investors |
03.09.2024 | - | $1.33M | - |
Mentions in press and media 8
Date | Title | Description |
11.11.2024 | Amferia and Chalmers University: Pioneering Innovations in Health and Technology | In a world where bacterial infections loom larger than ever, Swedish medtech company Amferia is stepping up to the plate. Recently, they snagged the prestigious Red Dot Award for their innovative design aimed at combating antibiotic resista... |
11.11.2024 | Amferia wins Red Dot Award for Innovative Design addressing bacterial infections and antibiotic resistance | Amferia wins Red Dot Award for Innovative Design addressing bacterial infections and antibiotic resistance Mon, Nov 11, 2024 10:00 CET Report this content Swedish medtech company Amferia has been awarded the Red Dot Award for its elevator p... |
30.10.2024 | First Product Utilizing Amferia Antimicrobial Technology Launched in Europe for Animal Wound Care | First Product Utilizing Amferia Antimicrobial Technology Launched in Europe for Animal Wound Care Wed, Oct 30, 2024 08:00 CET Report this content The Snögg BactiDefend Dressing, a new product in animal wound care using Amferia’s proprietary... |
03.09.2024 | Amferia closes €1,2 million investment to combat resistant bacterial infections | Amferia closes €1,2 million investment to combat resistant bacterial infections Tue, Sep 03, 2024 07:00 CET Report this content Swedish medtech company Amferia announces the successful completion of its latest investment round, boosting its... |
03.09.2024 | Swedish medtech Amferia snaps €1.2 million to combat resistant bacterial infections | Mölndal-based Amferia, a Swedish medtech company focused on developing innovative antimicrobial healthcare solutions, closed a €1,2 million investment round spearheaded by existing owners and a few new investors, including Chalmers Ventures... |
26.08.2024 | Amferia signs major animal health contract with Biokema and expands into Switzerland | Amferia signs major animal health contract with Biokema and expands into Switzerland Mon, Aug 26, 2024 11:56 CET Report this content Swedish medtech company Amferia, with a mission to combat infections globally, announces the signing of its... |
- | Amferia | “Amferia kills bacteria” |
- | Amferia | “Amferia | Amferia kills bacteria” |